fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 29, 2023

Primary Completion Date

April 28, 2024

Study Completion Date

May 15, 2024

Conditions
Parkinson's Disease
Interventions
DEVICE

Intermittent theta burst stimulation (iTBS)

iTBS: 90% RMT, 50Hz intraburst frequency, 3 pulses per burst, 5Hz interburst frequency, 2 seconds on/8 seconds off, totaling 1800 pulses over approximately 10 minutes. Each day includes 4 iTBS sessions (1800 pulses per session) with 50-minute intervals, totaling 7200 pulses per day for 14 consecutive days (100800 pulses total).

Trial Locations (1)

462000

Henan Provincial People's Hospital, Zhengzhou

Sponsors
All Listed Sponsors
collaborator

Henan Provincial People's Hospital

OTHER

lead

Changping Laboratory

OTHER

NCT06734676 - fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease | Biotech Hunter | Biotech Hunter